Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call

Presentation

Presentation: A Highly Potent Engineered AAV Capsid, STAC-150, Enables High-Throughput AAV Production and Arrayed Epigenetic Regulator Screening Directly in Cultured Neurons

Download PDF